Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Dexcom (DXCM) Shares Issued (2016 - 2025)

Dexcom (DXCM) has disclosed Shares Issued for 16 consecutive years, with $13.9 million as the latest value for Q3 2025.

  • Quarterly Shares Issued fell 6.08% to $13.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $28.1 million through Dec 2025, changed 0.35% year-over-year, with the annual reading at $28.1 million for FY2025, 0.35% changed from the prior year.
  • Shares Issued for Q3 2025 was $13.9 million at Dexcom, down from $14.2 million in the prior quarter.
  • The five-year high for Shares Issued was $14.8 million in Q3 2024, with the low at $8.7 million in Q1 2021.
  • Average Shares Issued over 5 years is $12.6 million, with a median of $12.9 million recorded in 2022.
  • The sharpest move saw Shares Issued soared 34.88% in 2021, then fell 6.08% in 2025.
  • Over 5 years, Shares Issued stood at $11.6 million in 2021, then rose by 6.9% to $12.4 million in 2022, then grew by 15.32% to $14.3 million in 2023, then grew by 3.5% to $14.8 million in 2024, then dropped by 6.08% to $13.9 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $13.9 million, $14.2 million, and $14.8 million for Q3 2025, Q1 2025, and Q3 2024 respectively.